Radiotherapy, chemotherapy, and other targeted therapies are commonly utilized in clinical cancer treatments to elicit an antitumor immune response because of their ability to activate the cGAS–STING pathway by producing DNA damage. The gene discussed is CGAS; the disease is cancer.